VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹459 Cr | ₹319 Cr | ₹267 Cr | ₹278 Cr | ₹301 Cr |
What is the latest Total Non-Current Assets ratio of VENUS REMEDIES ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹459 Cr |
| Mar2025 | ₹319 Cr |
| Mar2024 | ₹267 Cr |
| Mar2023 | ₹278 Cr |
| Mar2022 | ₹301 Cr |
How is Total Non-Current Assets of VENUS REMEDIES Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹459 Cr | 43.82 | |
| Mar2025 | ₹319 Cr | 19.27 | |
| Mar2024 | ₹267 Cr | -3.93 | |
| Mar2023 | ₹278 Cr | -7.59 | |
| Mar2022 | ₹301 Cr | - | |
Compare Total Non-Current Assets of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,237.9 Cr | 4.8% | 3.5% | 278.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 4.8% |
3.5% |
278.5% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses